Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer
<p>Abstract</p> <p>Background</p> <p>Successful treatment of solid tumors relies on the ability of drugs to penetrate into the tumor tissue.</p> <p>Methods</p> <p>We examined the correlation of panitumumab (an anti-epidermal growth factor [EGFR]...
Main Authors: | Freeman Daniel J, McDorman Kevin, Ogbagabriel Selam, Kozlosky Carl, Yang Bing-Bing, Doshi Sameer, Perez-Ruxio Juan, Fanslow William, Starnes Charlie, Radinsky Robert |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://www.molecular-cancer.com/content/11/1/47 |
Similar Items
-
The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts
by: Job Komen, et al.
Published: (2022-05-01) -
Zebrafish xenograft model of human lung cancer for studying the function of LINC00152 in cell proliferation and invasion
by: Wenyi Shen, et al.
Published: (2020-08-01) -
Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report
by: Hitomi Kamo, et al.
Published: (2019-01-01) -
Lycopene minimizes skin toxicity and oxidative stress in patients treated with panitumumab-containing therapy for metastatic colorectal cancer
by: Mauro Moroni, et al.
Published: (2021-08-01) -
Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer
by: Pui Lam Yip, et al.
Published: (2023-04-01)